Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005149
Filing Date
2024-11-14
Accepted
2024-11-14 16:01:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 armistice-dcph093024a3.htm SC 13G/A 89023
  Complete submission text file 0001172661-24-005149.txt   90660
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Subject) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90130 | Film No.: 241461535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)